Patent Strategy for Startups: File First, Fix Your Paperwork, and Know What the Evidence Says

What Founders Actually Need

Most startup patent advice falls into one of two camps: file everything, or patents do not matter. Neither holds up well. For an early-stage company, the useful list is short and not glamorous: file before you disclose, make sure the company owns what it thinks it owns, and be honest about what a patent will and will not do for you.

File Before You Disclose

The United States gives you a one-year grace period for your own disclosures (35 USC 102). Europe does not work that way. The European Patent Convention counts everything made available to the public (EPC Art. 54), with narrow exceptions for evident abuse and recognized exhibitions (EPC Art. 55).

So "we have a year" is US-only advice. A public demo, a preprint or a public code repository before filing can cost you European rights while leaving your US rights intact.

Secrecy does not guarantee safety either. In Helsinn, the Supreme Court held that a sale to a third party obliged to keep the invention confidential can still put it "on sale" (Helsinn v. Teva). Early commercial deals count, so talk to counsel before signing the first one.

The Standard Timeline

If you want international options, the usual path looks like this:

Month 0: First filing, often a provisional. See our provisional vs. non-provisional guide.
Month 12: Paris Convention priority deadline (Paris Convention Art. 4). File your non-provisional, and a PCT application if you want foreign rights.
Month 18: Publication, unless you qualify for and make a nonpublication request (35 USC 122).
Months 30 to 31: National phase entry. It is 30 months in the US, Japan and Canada, and 31 at the EPO, Korea, Australia and India (WIPO PCT Time Limits).

That sequence defers most foreign costs by about two and a half years, which often spans a financing round. Our global filing guide has more detail on choosing countries.

One more deadline often catches remote teams out. For an invention made in the US, filing abroad within six months of the US filing without a foreign filing license can bar or invalidate the patent (35 USC 184; 35 USC 185). Your filing receipt shows whether a license was granted (MPEP 140).

Ownership Is Where Deals Get Stuck

Patent rights start with the individual inventors and pass only in writing. As the Supreme Court put it, a patent is property, and title can pass only by assignment (United States v. Dubilier). If nobody signed anything, your company may not own your core technology.

Four traps come up repeatedly:

"Agree to assign" is not "hereby assign." In Stanford v. Roche, a researcher agreed to assign to Stanford, then later signed an agreement stating "will assign and do[es] hereby assign" to Cetus, and the Federal Circuit gave Cetus priority. The Supreme Court expressly did not rule on that wording question (Stanford v. Roche), so the rule comes from Federal Circuit law, which says "will assign" language alone does not create an immediate assignment (Advanced Video v. HTC). Use present-tense language.

A missing co-inventor is a co-owner. Each joint owner may exploit the patent without consent and without accounting to the others (35 USC 262). That means a departed co-founder who never assigned could license your competitor. In Advanced Video, a non-assigning co-inventor's retained interest ended the lawsuit for lack of standing.

Contractors do not assign by default. Commissioned software is not automatically a work for hire (17 USC 101; CCNV v. Reid), and a copyright transfer requires a signed writing (17 USC 204). Your contractor agreements need to cover patents and copyright.

Unrecorded assignments are exposed. An assignment is void against a later purchaser without notice unless it is recorded within three months or before that later purchase (35 USC 261). Electronic recording currently has no USPTO fee (MPEP 302), so there is no reason to skip it.

Also check prior employers and universities. A prior "hereby assign" clause can beat a later assignment to your startup. If federal funding was involved, including SBIR or STTR grants, Bayh-Dole disclosure and election duties can put title at risk (35 USC 202).

Do Patents Help You Raise Money?

The best evidence says yes, with some important caveats.

Farre-Mensa, Hegde and Ljungqvist used differences in examiner leniency to study first-time applicants. Startups that won their first patent had, on average, 55% higher employment growth and 80% higher sales growth five years later (NBER w23268). A first patent raised the odds of VC funding over three years by 47%.

The fine print matters (NBER Full Text):

The base rates are small. Among startups with no prior VC funding, the gain was 1.3 percentage points on a 1.7% base, so most patent winners still raised no VC.
The effect concentrates among inexperienced founders. For experienced teams, it was virtually zero.
It measures winning at the margin. It does not show that any weak invention benefits from a filing.

Other research adds nuance. Gaulé found a large effect of patents on firm success, but only for life science firms (Gaulé, 2018). In the Berkeley Patent Survey, the most common reasons startups gave for not patenting were the cost of obtaining and of enforcing patents (Berkeley Patent Survey). That survey dates from 2008 and predates the current rules, so read its figures as history.

A patent can be a real signal, especially for a first-time team in a technical field. It does not replace traction, and it does not guarantee a round.

What Investors Check

Look at the NVCA's model stock purchase agreement, dated October 2025 (NVCA Model Documents). The intellectual property representations focus on title and risk, not patent counts (NVCA Model SPA). They cover whether the company has the rights it needs for its business, whether employees and consultants have assigned their rights, open-source "copyleft" obligations, and university and government funding. The form also adds an optional generative AI representation. A validity representation is optional, and only for critically important patents.

So a clean file matters more than a long patent list. Before diligence starts, gather:

Founder and employee invention assignments in present-tense form
Contractor agreements and recorded assignments
A license list and an open-source inventory
University, grant and prior-employer history
Any demand letters, including those you ignored
Your policy on generative AI tools

Getting to Grant Faster

First-action pendency was 20.5 months at the end of FY2026 (USPTO FY2026 Pendency Review), which can outlast a seed runway. Track One aims for final disposition in about twelve months (USPTO Track One Page). The request costs $4,515, $1,806 or $903 depending on entity size (USPTO Fee Schedule), and annual requests are capped at 20,000 (90 FR 29990).

Be careful with older guides: utility Accelerated Examination has ended, and the Streamlined Claim Set Pilot closed on October 27, 2026 (USPTO Pilot Page). Under-resourced inventors can look at the USPTO Patent Pro Bono Program.

Check your entity status at each payment too. Micro entity status is easy to lose once you have funding, because it depends on income limits and on who holds an interest in the application (37 CFR 1.29).

Patent or Trade Secret?

A patent requires publication. A trade secret requires secrecy and reasonable protective measures (18 USC 1839), has no fixed time limit (USPTO Trade Secret Policy), and offers no protection against reverse engineering or independent discovery.

A useful rule of thumb, in our view: if a competitor can learn it by buying your product, secrecy offers little. If it stays behind the wall, such as a process, model weights or a training pipeline, secrecy often fits better. For applied machine learning, eligibility problems may decide the question for you.

Watch for two details. First, the choice can close. Selling products made with a secret process can bar a later patent on that process once the critical date has passed (Celanese v. ITC). Second, your employee and contractor agreements should include the Defend Trade Secrets Act whistleblower notice, or you lose exemplary damages and fees against that person (18 USC 1833).

The Bottom Line

File before you disclose, assign in the present tense, record it, and spend your patent budget on what would actually hurt if a competitor copied it. Everything else is optional until a round or a rival makes it urgent.

Obsidyan's invention capture and drafting tools help small teams get inventions documented without slowing down, and deadline tracking keeps the 12-month and 30-month dates visible. Have a patent attorney review ownership documents and filing decisions.

Sources

Sources checked November 6, 2026. Fees, pilot programs and pending rules change, so confirm current figures with the USPTO. This article is general information, not legal advice, and Obsidyan is not a law firm. Talk to a registered patent attorney or agent about your situation.